CYP cynata therapeutics limited

9.68%

17.0¢

Ann: Capital Raising Presentation, page-70

First 70 Last

Share
Profile

Follow
JB1975

2,282 Posts.

1205

17/04/23

11:13

Post #: 67308593
Share

Originally posted by JB1975: ↑

On page 5 of the presentation pdf, under the heading Why Mesenchymal Stem Cells (MSCs)? is a reference to 2 Kelly K and Rasko J. Frontiers in Immunology. 12 October 2021.

I've just come from checking the Frontiers in Immunology website for the second time - here is the link
https://www.frontiersin.org/journals/immunology/volumes?volume-id=735

I could not find the paper in the time zone 12 October 2021 or by searching on Kelly or Rasko and the paper's title isn't included in the reference.

I did see 23 other papers on 12 October 2021 but a match for the reference on the presentation was not there - unless I missed it twice now.

Could someone please confirm ?

I am familiar with the other referenced paper - Aggarwal et al 2005 - its quite some time ago - and a favored reference by Mesoblast in ODAC submissions and patent processing updates etc? 2005 is really quite some time ago. A lot has changed in terms of the technology that can be brought to bare to profile cells - so I'd like to see what work Kelly and Rasko actually have done more recently. The other immunology articles around and since 2021 suggest the work is considerable.

Expand

MINI REVIEWpublished: 26 October 2021doi: 10.3389/fimmu.2021.761616

I found it using the quoted text on page 5. The date was wrong its 26 October 2021.

Article is titled Mesenchymal Stromal Cells for the Treatment of Graft Versus HostDisease
https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8577186/

Its free.

CYP Price at posting: 20.0¢ Sentiment: None Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

SRL

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

OCC

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

PAR

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

BPH

Australia’s gas crisis is here – and dying coal plants aren’t helping

BOE

Boss extends June win streak with boosted Alta Mesa extraction rates

First 70 Last

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last 17.0¢		Change 0.015(9.68%)		Mkt cap ! $38.41M

Open	High	Low	Value	Volume
15.5¢	17.0¢	15.5¢	$47.10K	289.1K

Buyers (Bids)

No.	Vol.	Price($)
1	50000	16.5¢

Sellers (Offers)

Price($)	Vol.	No.
17.0¢	23813	3

View Market Depth

No.	Vol.	Price($)
1	50000	0.165
4	47240	0.155
4	161673	0.150
1	5000	0.145
2	45000	0.140

Price($)	Vol.	No.
0.170	23813	3
0.175	55250	1
0.180	62619	3
0.185	35990	1
0.195	19300	1

Last trade - 16.10pm 27/06/2025 (20 minute delay)

CYP (ASX) Chart

Ann: Capital Raising Presentation, page-70

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Capital Raising Presentation, page-70

Top Stories

'Not possible' to port renewable gas: ACCC takes AGN to court

Listen: HotCopper Wire Podcast 015 – Yeah, we're thinking the IPO market is back

Sunrise pops on top scandium hits NSW explorer will now use for 'multi-decade' plan

Orthocell sees 4% jump as Remplir used in first US surgery. But is that low?

ASX Market Close: Index creeps lower as half-year mark approaches | June 26

ASX Market Open: IPO hype, Wall Street ATHs push Aussies into green hope | June 27

Paradigm Biopharmaceuticals makes key acquisition moving into FY26

NATO’s 5% target: Why Almonty Industries’ mega mine and NASDAQ listing are a perfect fit for investors

Australia’s gas crisis is here – and dying coal plants aren’t helping

Boss extends June win streak with boosted Alta Mesa extraction rates

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News